The Mechanisms of the Improvement of Insulin Sensitivity by Angiotensin Converting Enzyme Inhibitor

References

• Reaven G M. Role of insulin resistance in human disease. Diabetes 1988; 37: 1595–1607
   PubMed Web of Science ®Google Scholar
• Kaplan N M. The deadly quartet Upperbody obesity, glucose intolerance in hypertriglycemia and hypertension. Arch Intern Med 1989; 149: 1514–1520
   PubMed Web of Science ®Google Scholar
• DeFronzo R A, Ferrannini E. Insulin resistance — A multifactorial syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care 1991; 14: 173–194
   PubMed Web of Science ®Google Scholar
• Modan M, Or J, Karasik A, Drory Y, Fuchs Z, Lusky A, Chetrit A, Halkin H. Hyperinsulinemia, sex and risk of atherosclerotic cardiovascular disease. Circulation 1991; 84: 1165–1175
   PubMed Web of Science ®Google Scholar
• Ferrannini E, Buzzigoli G, Bonadonna R, Giorico M A, Oleggini M, Graziadei L, Pedrinelli R, Brandi L, Bevilacqua S. Insulin resistance in essential hypertension. N Engl J Med 1987; 316: 350–357
   Google Scholar
• Pollare T, Lithell H, Berne C. A comparison of the effects of hydrochlorothiazide and captopril on glucose and lipid metabolism in patients with hypertension. N Engl J Med 1989; 321: 868–873
   PubMed Web of Science ®Google Scholar
• Rett K, Lotz N, Wicklmayr M, Fink E, Jauch K W, Gunther B, Dietze G. Verbesserte Insulinwirkung durch ACE-Hemmung beim Typ-II-Diabetiker. Dtsch Med Wochenschr 1988; 113: 243–249
   PubMedGoogle Scholar
• Paolisso G, Gambardella A, Verza M, D'Amre A, Sgambato S, Varricchio M. ACE inhibition improves insulin sensitivity in aged insulin-resistant hypertensive patients. J Hum Hypertens 1992; 6: 175–179
   PubMed Web of Science ®Google Scholar
• Tomiyama H, Kushiro T, Abeta H, Ishii T, Takahashi A, Furukawa L, Asagami T, Hino T, Saito F, Otsuka Y, Kurumatani H, Kobayashi F, Kanmatsuse K, Kajiwara N. Kinins contribute to the improvement of insulin sensitivity during treatment with angiotensin converting enzyme inhibitor. Hypertension 1994; 23: 450–455
   PubMed Web of Science ®Google Scholar
• Zavaroni I, Sanders S, Scott S, Reaven G M. Effect of fructose feeding on insulin secretion and insulin action in the rat. Metabolism 1980; 29: 970–973
   PubMed Web of Science ®Google Scholar
• Tobey T A, Mondon C E, Zavaroni I, Reaven G M. Mechanism of insulin resistance in fructose-fed rats. Metabolism 1982; 31: 608–612
   PubMed Web of Science ®Google Scholar
• Reaven E P, Wright D W, Mondon C E, Solomon R, Ho H, Reaven G M. Effect of age and diet on insulin secretion and insulin action in the rat. Diabetes 1983; 32: 175–180
   PubMed Web of Science ®Google Scholar
• Reaven G M, Ho H, Hoffman B B. Attenuation of fructose-induced hypertension in rats by exercise training. Hypertension 1988; 12: 129–132
   PubMed Web of Science ®Google Scholar
• Lucas C P, Estigarribia J A, Darga L L, Reaven G M. Insulin and blood pressure in obesity. Hypertension 1985; 7: 702–706
   PubMed Web of Science ®Google Scholar
• Modan M, Halkin H, Almog S, Lusky A, Eskol A, Shefi M, Shitrit A, Fuchs I. A link between hypertension, obesity and glucose intolerance. J Clin Invest 1985; 75: 809–817
   PubMed Web of Science ®Google Scholar
• Singer P, Godicke W, Voit S, Haj I, Weiss M. Postprandial hyperinsulinemia in patients with mild hypertension. Hypertension 1985; 7: 182–186
   PubMed Web of Science ®Google Scholar
• Shimamoto K, Nakagawa M, Higashiura K, Miyazaki Y, Shiiki M, Masuda A, Iimura O. Insulin sensitivity and renal sodium-water metabolism in obese normotensive subjects. Ann NY Acad Sci 1993; 676: 345–349
   PubMed Web of Science ®Google Scholar
• Shimamoto K, Hirata A, Fukuoka M, Higashiura K, Miyazaki Y, Shiiki M, Masuda A, Nakagawa M, Iimura O. Insulin sensitivity and the effects of insulin on renal sodium handling and pressor systems in essential hypertensive patients. Hypertension 1994; 23(Suppl I)I-29–I-33
   Google Scholar
• Shimamoto K, Matsuda K, Takizawa H, Higashiura K, Ura N, Iimura O. Effects of an angiotensin II receptor antagonist, TCV-116, on insulin sensitivity in fructose-fed rats. Blood Pressure 1994; 3(Suppl 5)113–116
   Google Scholar
• Iimura O, Shimamoto K, Matsuda K, Masuda A, Takizawa H, Higashiura K, Miyazaki Y, Hirata A, Ura N, Nakagawa M. Effects of angiotensin receptor antagonist and angiotensin converting enzyme inhibitor on insulin sensitiity in fructose-fed hypertensive rats and essential hypertensives. Am J Hypertens 1995; 8: 353–357
   PubMed Web of Science ®Google Scholar
• Moan A, Risanger T, Eide I, Kjeldsen S E. The effect of angiotensin II receptor blockade on insulin sensitivity and sympathetic nervous system activity in primary hypertension. Blood Pressure 1994; 3: 185–188
   PubMedGoogle Scholar
• Townsend R R, DiPette D J. Pressor doses of angiotensin II increase insulin-mediated glucose uptake in normotensive men. Am J Physiol 1993; 265: E362–E366
   PubMed Web of Science ®Google Scholar
• Buchanan T A, Thawani H, Kades W, Modrall J G, Weaver F A, Laurel C, Poppiti R, Xiang A, Hsueh W. Angiotensin II increases glucose utilization during acute hyperinsulinemia via a hemodynamic mechanism. J Clin Invest 1993; 92: 720–726
   PubMed Web of Science ®Google Scholar
• Iimura O, Shimamoto K, Tanaka S, Hosoda S, Nishimiya T, Ando T, Masuda A. The mechanism of the hypotensive effect of captopril (converting enzyme inhibitor) with special reference to the kallikrein-kinin and renin-angiotensin systems. Jpn J Med 1986; 25: 34–39
   PubMedGoogle Scholar
• Tanaka S, Shimamoto K, Ando T, Nakahashi Y, Ura N, Hosoda S, Ishida H, Yamaji I, Yokoyama T, Masuda A, Iimura O. Role of renin-angiotensin and kallikrein-kinin systems on the mechanism of the hypotensive effect of converting enzyme inhibitor, Alacepril. Clin Exp Hypertens 1987; A9: 605–609
   Google Scholar
• Bao G, Gohlke P, Qadri F, Unger T. Chronic kinin receptor blockade attenuates the antihypertensive effect of ramipril. Hypertension 1992; 20: 74–79
   PubMed Web of Science ®Google Scholar